New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.
Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...
Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...
Study Finds on MSN3d
The Great Aspirin Debate: Why Age-Based Guidelines Are Being QuestionedIn a nutshell Current guidelines restricting aspirin based on age alone may be flawed; researchers argue decisions should be ...
Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And ...
Aspirin, a widely available and inexpensive drug, has failed to improve survival or reduce recurrence rates in women with early-stage but high-risk breast cancer, according to a Harvard-led clinical ...
Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ...
News-Medical.Net on MSN6d
Research shows clopidogrel as better long-term therapy than aspirin after PCIPeople at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...
Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback